Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Podpisana zgoda pacjenta na udział w badaniu
- •Wiek co najmniej 18 lat
- •Pacjent identyfikujący się jako rdzenny Amerykanin
- •Potwierdzona diagnoza raka prostaty (dowolny stopień zaawansowania)
- •Dostępne próbki archiwalne z guza
✗ Disqualifies
- •Pacjent nie jest pochodzenia lub tożsamości rdzennego Amerykanina
- •Brak dostępnych próbek archwalnych tkanki guza
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 100 Years
- Last updated (source)
- August 26, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
OU Health Stephenson Cancer Center
Oklahoma City, United States
Trial contact
Lead Onco Nurse
Adanma Ayanambakkam, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/27/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.